Bafna PharmaceuticalsBAFNAPH 
$0.972.95%24h
2.95%24h
Global rank29391
Market cap$22.94M
Change 7d-0.21%
YTD Performance-11.60%
SP500 benchmarkUnderperform
P/E0.20
P/S1.67
Revenue$13.75M
Earnings$1.35M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Bafna Pharmaceuticals (BAFNAPH)
Bafna Pharmaceuticals has an EPS of $4.792864. In 2022, the company made an earnings per share (EPS) of $2.205064. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for BAFNAPH
-
Value:-
EPS history for Bafna Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $4.79 | 117.36% |
| 2022 | $2.21 | -10.36% |
| 2021 | $2.46 | -102.31% |
| 2020 | -$106.54 | - |
View the highest EPS stocks
